True Blue (TBI) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $16 price target. Company is leveraged to rising ISM new orders index and could see more demand following Hurricane Sandy.
Vertex Pharmaceuticals (VRTX) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $43 price target. Have a more cautious outlook for the company's cystic fibrosis portfolio.
Watson Pharmaceuticals (WPI) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $103 price target. Company offers growth at a reasonable price.
STOCK COMMENTS / EPS CHANGESLinkedIn (LNKD) numbers boosted at Citi. Shares of LNKD now seen reaching $135, according to Citigroup. Estimates also upped, as the company is gaining market share. Buy rating.
Priceline.com (PCLN) numbers raised at Goldman. Shares of PCLN now seen reaching $770, according to Goldman Sachs. Estimates also increased, as the company is realizing higher bookings growth. Buy rating.Pfizer (PFE) estimates, target reduced at BMO. PFE estimates were cut through 2013, BMO Capital said. Company is being hurt by the stronger dollar. Outperform rating and new $29 price target. Starbucks (SBUX) estimates, target raised at BofA/Merrill. Shares of SBUX now seen reaching $60, according to Bank of America/Merrill Lynch. Estimates also increased, as new products are driving growth. Buy rating. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV